| DERM | PRESS-RELEASE | bearish | 6/10 | Journey Medical reported Q1 2026 EPS of -$0.08, a 255.6% miss vs consensus of -$0.02, with revenue of $18.5M slightly ab | Aug 12, 2026 |
| DAIO | PRESS-RELEASE | bearish | 6/10 | Data I/O Corporation reported Q1 2026 EPS of -$0.21, a 425% miss versus the $0.04 consensus estimate, on revenue of $5.2 | Aug 12, 2026 |
| USIO | PRESS-RELEASE | bullish | 7/10 | Usio reported Q1 2026 revenue of $23.7M (+19% YoY), in line with consensus, and GAAP EPS of $0.00, beating the consensus | Aug 12, 2026 |
| BBGI | PRESS-RELEASE | bearish | 6/10 | Beasley Media Group reported Q2 2026 net revenue of $44.1M, down 16.8% YoY from $53.0M, and a GAAP net income of $84.3M | Aug 12, 2026 |
| HY | PRESS-RELEASE | neutral | 5/10 | No summary provided | Aug 12, 2026 |
| LPLA | PRESS-RELEASE | bearish | 5/10 | LPL Financial reported Q2 2026 EPS of $5.84, a 2.2% miss versus consensus of $5.97, though revenue was not explicitly st | Aug 12, 2026 |
| GNT | PRESS-RELEASE | neutral | 3/10 | GNT declared monthly cash distributions of $0.06 per share for October, November, and December 2026, continuing its poli | Aug 12, 2026 |
| NXXT | PRESS-RELEASE | neutral | 1/10 | NextNRG, Inc. announced it will host a conference call on August 13, 2026 to discuss its Q2 2026 results. | Aug 12, 2026 |
| GGZ | PRESS-RELEASE | neutral | 2/10 | The Gabelli Global Small and Mid Cap Value Trust declared a $0.21 per share quarterly cash distribution, payable Septemb | Aug 12, 2026 |
| GGT | PRESS-RELEASE | neutral | 2/10 | The Gabelli Multimedia Trust (GGT) announced continuation of its monthly cash distribution policy at $0.22 per share qua | Aug 12, 2026 |
| GLU | PRESS-RELEASE | neutral | 2/10 | The Gabelli Global Utility & Income Trust (GLU) declared monthly cash distributions of $0.11 per share for October, Nove | Aug 12, 2026 |
| GDL | PRESS-RELEASE | neutral | 2/10 | The GDL Fund declared a $0.12 per share quarterly cash distribution, payable September 23, 2026 to shareholders of recor | Aug 12, 2026 |
| ECF | PRESS-RELEASE | neutral | 3/10 | Ellsworth Growth and Income Fund Ltd. (ECF) declared a $0.22 per share quarterly cash distribution, a 16% increase from | Aug 12, 2026 |
| MNPR | PRESS-RELEASE | bullish | 6/10 | Monopar Therapeutics reported a Q2 2026 net loss of $5.3M ($0.62/share), wider than the $2.5M loss in Q2 2025, driven by | Aug 12, 2026 |
| LVO | PRESS-RELEASE | bearish | 5/10 | LiveOne reported Q1 Fiscal 2027 revenue of $19.35M, essentially flat year-over-year ($19.21M), and a GAAP net loss of -$ | Aug 12, 2026 |
| NEON | PRESS-RELEASE | neutral | 5/10 | No summary provided | Aug 12, 2026 |
| FLYW | PRESS-RELEASE | neutral | 3/10 | Flywire announced an expanded partnership with Trustly to offer open banking payments in the U.S. and Canada, building o | Aug 12, 2026 |
| APRE | PRESS-RELEASE | neutral | 5/10 | Aprea Therapeutics reported Q2 2026 results with a net loss of $3.6M ($-0.07/share), widening from a $3.2M loss in Q2 20 | Aug 12, 2026 |
| DYAI | PRESS-RELEASE | bearish | 7/10 | Dyadic International reported Q2 2026 revenue of $961,138, essentially flat year-over-year (-0.6%), and a net loss of $2 | Aug 12, 2026 |
| EHLD | PRESS-RELEASE | bullish | 6/10 | Euroholdings reported Q2 2026 net revenues of $8.6M (up 195% YoY) and net income of $4.3M ($1.52 EPS), driven by a third | Aug 12, 2026 |
| KN | PRESS-RELEASE | neutral | 3/10 | Knowles Corporation announced a manufacturing agreement with Elucent Medical to produce a smart surgical guidance device | Aug 12, 2026 |
| LIQT | PRESS-RELEASE | bearish | 7/10 | LiqTech reported Q2 2026 revenue of $4.4M (down 12% YoY) and a net loss of $(3.1)M, missing consensus EPS of $(0.19) by | Aug 12, 2026 |
| HSDT | PRESS-RELEASE | neutral | 1/10 | Solana Company announced it will report its Q2 2026 results on August 14, 2026. | Aug 12, 2026 |
| ANTA | PRESS-RELEASE | neutral | 1/10 | Antalpha Platform Holding Company announced it will report its Q2 2026 results on August 19, 2026. | Aug 12, 2026 |
| PODC | PRESS-RELEASE | mixed | 5/10 | PodcastOne reported Q1 Fiscal 2027 revenue of $16.1M (+8% YoY), beating the $17.8M consensus, but GAAP EPS of -$0.05 mis | Aug 12, 2026 |
| IPSC | PRESS-RELEASE | bearish | 5/10 | Century Therapeutics reported Q2 2026 EPS of -$0.17, a 55.3% miss vs consensus of -$0.11, with no revenue. The company h | Aug 12, 2026 |
| PYPD | PRESS-RELEASE | bullish | 7/10 | PolyPid reported Q2 2026 EPS of -$0.35, beating consensus of -$0.38 by 7.3%, with no revenue. The key catalyst is the FD | Aug 12, 2026 |
| ALT | PRESS-RELEASE | neutral | 5/10 | Altimmune reported Q2 2026 net loss of $0.12 per share, beating consensus of -$0.13 by 7.7%, but this is a mechanical ar | Aug 12, 2026 |
| ADAG | PRESS-RELEASE | mixed | 6/10 | Adagene reported H1 2026 net loss of $16.4M, wider than $13.5M in H1 2025, with EPS of -$0.23 vs consensus -$0.08 (a 187 | Aug 12, 2026 |
| BWAY | PRESS-RELEASE | bullish | 7/10 | BrainsWay reported Q2 2026 revenue of $17.1M (+35% YoY), EPS of $0.07 (GAAP), and raised FY 2026 revenue guidance to $68 | Aug 12, 2026 |